Bone Growth

Adolescent boys exposed to higher levels of two types of endocrine-disrupting chemicals may have lower areal bone mineral density, according to study data published in The Journal of Clinical Endocrinology & Metabolism.

Postmenopausal women experienced more widespread vertebral bone accrual at the lumbar spine at 12 months of romosozumab treatment compared with teriparatide, according to study data published in the Journal of Bone and Mineral Research.

Active Life Scientific Inc. has received FDA de novo clearance for Bone Score, a new approach to measuring bone and bone tissue, according to a press release.

Boys who engaged in high-impact exercise in early adolescence experienced greater gains in bone mineral density compared with boys who reported no exercise practice, data from a population-based study show.

A subcutaneous injection of leuprolide acetate every 6 months was effective and well tolerated in treating central precocious puberty in children, according to trial data.

Transgender adolescents treated with gender-affirming hormone therapy early in puberty experience bone development more similar to that of their experienced gender compared with their gender assigned at birth, according to study data.

Anatomic total shoulder arthroplasty with a partially cemented polyethylene glenoid component, or anchor peg implant, may yield “in between fin” bone growth and decreased pain, according to recently presented results.

Palovarotene reduced new heterotopic ossification volume in children and adults with fibrodysplasia ossificans progressiva, according to data from a phase 3 trial.

During a meeting of the Orthopaedic and Rehabilitation Devices Panel of the FDA Medical Devices Advisory Committee, panel members found noninvasive bone growth stimulators worthy of down-classification.

Orthofix announced an updated version of its bone growth stimulator app, STIM onTrack, was approved by the FDA.